April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium
Author Affiliations & Notes
  • Sandeep Kumar
    John A Moran Eye Center, University of Utah, Salt Lake City, UT
  • Zachary Berriochoa
    John A Moran Eye Center, University of Utah, Salt Lake City, UT
  • Alex Jones
    John A Moran Eye Center, University of Utah, Salt Lake City, UT
  • Yingbin Fu
    John A Moran Eye Center, University of Utah, Salt Lake City, UT
  • Footnotes
    Commercial Relationships Sandeep Kumar, None; Zachary Berriochoa, None; Alex Jones, None; Yingbin Fu, Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof, and (P), Small vessel disease and fibrosis of the choroid and AMD with pseudo drusen and reticular drusen. (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5237. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sandeep Kumar, Zachary Berriochoa, Alex Jones, Yingbin Fu; Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5237.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Polypoidal choroidal vasculopathy (PCV) is characterized by branching vascular network (BVN) with terminal polypoidal dilations (polyps) in choroid. Previously, we reported the generation of the first PCV model by transgenically expressing human HTRA1 in mouse retinal pigment epithelium. Here, we performed comprehensive examinations on PCV phenotypes (e.g. lesion type, distribution) of HTRA1 mice by a variety of in vivo imaging techniques. Especially, we have applied the technique of Indocyanine Green Angiography via tail-vein injection (IV-ICGA) to mouse models for the first time to obtain high quality ICGA comparable to human studies in terms of the three phases (early, middle, and late) of angiography.

 
Methods
 

We compared the influence of delivery route (Intraperitoneal injection (IP) vs. IV, >100 mice for each method) and mouse coat color (albino vs. pigmented) on ICGA using HTRA1 and WT mice. 125 HTRA1 mice (1-14 months) and 55 wild-type littermate controls were examined by IV-ICGA, fluorescein angiography, funduscopy, and spectral-domain optical coherence tomography (SD-OCT).

 
Results
 

Our data suggest that, 1) IV-ICGA is superior to IP (or subcutaneous (SC))-ICGA that are currently used in animal research for characterizing lesions in the choroid; 2) ICGA performed on albino mice gives clearer pictures of choroidal vessels than that performed on pigmented mice. On IV-ICGA, the two key features of PCV (BVN and polyps) are present in 118 HTRA1 mice (out of 125). Polyps can be detected in the early “fill-in” phase of ICGA, most lesions become visible in the middle phase and become more distinct in the late phase with the fading of surrounding vessels. HTRA1 mice exhibit additional features of PCV such as late geographic hyperfluorescence, pigment epithelium detachment, and hyperfluorescent plaque. On funduscopy, polypoidal lesions appear as reddish orange nodules. SD-OCT located lesions in the choroid and round protrusions of the RPE underneath the polyps. These phenotypes share remarkable similarities to the well established clinical features of human PCV. Currently, no other animal models exist with these features.

 
Conclusions
 

HTRA1 mice exhibit a rich spectrum of “clinical” features that closely mimic human PCV, making it an invaluable tool for future mechanistic and translational studies of this disease and other forms of choroidal vasculopathies.

 
Keywords: 412 age-related macular degeneration • 452 choroid • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×